Mendus (IMMU.ST) traded up 5.66 % during a 24 hours period ending at 02:04 AM Central Europe on Tuesday 27th. One Mendus stock can currently be bought for about SEK 5.49 on popular exchanges. Current supply of Mendus stocks is 66.3 mn. Mendus has a current market capitalization of SEK 371.4 mn and approximately SEK 157.8 k worth of Mendus was traded on exchanges in the last 24 hours. Since last month end, Mendus has traded -17.28 % down. Simple moving average of last 200 days is at SEK 5.69. The highest price of past 52 weeks was recorded at SEK 8.49 on 09/01/2026. 52 weeks low was at SEK 3.86 on 03/25/2026.

Here is how related stocks have performed in the past 24 hours:

  • Qliro (QLIRO.ST) traded up 0.39 % and now trades at SEK 12.5. Current market capitalisation for Qliro is SEK 438.3 mn.

  • Botnia Gold (BOTX.ST) traded down -0.58 % and now trades at SEK 10.36. Botnia Gold has a market capitalisation of SEK 420.3 mn. Current price/earnings ratio for Botnia Gold is 6.96.

  • Akobo Minerals (AKOBO.OL) traded down -7.86 % and now trades at NOK 1.75. Akobo Minerals has a market capitalisation of NOK 437.7 mn.

  • Krona Public Real Estate (927.F) traded flat 0 % and now trades at EUR 3.48. Current market capitalisation for Krona Public Real Estate is EUR 38.9 mn. Krona Public Real Estate has a current price to earnings ratio of 8.45.

  • Solnaberg Property (SOLNA.ST) traded flat 0 % and now trades at SEK 118. Solnaberg Property has a market capitalisation of SEK 443.7 mn. Solnaberg Property has a current price to earnings ratio of 9.05.


About Mendus

Mendus AB is a biopharmaceutical company operating in the health care sector with a focus on developing novel maintenance therapy solutions with favorable safety profiles for tumors associated with a high recurrence rate. The company spezializes in allogeneic dendritic cell biology to develop novel, off-the-shelf, and cell-based therapies for both solid and blood-borne tumors.